<DOC>
<DOCNO>EP-0647627</DOCNO> 
<TEXT>
<INVENTION-TITLE>
1,2-Dihydro-2-oxo-3-methylsulfonylaminomethyl-pyridines as angiotensin II antagonists.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3144	A61K3144	A61K314418	A61K314418	A61K314427	A61K314427	A61P900	A61P900	A61P912	A61P2700	A61P2702	A61P4300	A61P4300	C07D21300	C07D21338	C07D21364	C07D40100	C07D40110	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P9	A61P9	A61P9	A61P27	A61P27	A61P43	A61P43	C07D213	C07D213	C07D213	C07D401	C07D401	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Novel 1,2-dihydro-2-oxo-3-methylsulphonylaminomethylpyridines of the formula I 
<
IMAGE
>
  wherein     R
<
1
>
 is alkyl having 1-5 C atoms,   R
<
2
>
 is CN or 1H-tetrazol-5-yl and   R
<
3
>
 is alkyl having 1-5 C atoms or cyclopropylmethyl, and their salts show angiotensin II-antagonistic properties and can be used for the treatment of hypertension, aldosteronism and cardiac insufficiency.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
MERCK PATENT GMBH
</APPLICANT-NAME>
<APPLICANT-NAME>
MERCK PATENT GMBH
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BEIER NORBERT DR
</INVENTOR-NAME>
<INVENTOR-NAME>
DORSCH DIETER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
LUES INGEBORG DR
</INVENTOR-NAME>
<INVENTOR-NAME>
MEDERSKI WERNER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
MINCK KLAUS-OTTO DR
</INVENTOR-NAME>
<INVENTOR-NAME>
OSSWALD MATHIAS DR
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHELLING PIERRE PROF DR
</INVENTOR-NAME>
<INVENTOR-NAME>
BEIER, NORBERT, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
DORSCH, DIETER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
LUES, INGEBORG, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
MEDERSKI, WERNER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
MINCK, KLAUS-OTTO, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
OSSWALD, MATHIAS, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHELLING, PIERRE, PROF. DR.
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
